Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
AstraZeneca
McKesson
Queensland Health
Julphar
McKinsey

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,382,321

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,382,321
Title:Effector-deficient anti-CD32A antibodies
Abstract: Effector-deficient anti-CD32a monoclonal antibodies are encompassed, as are method and uses for treating CD32a-mediated diseases and disorders, including, thrombocytopenia, allergy, hemostatic disorders, immune, inflammatory, and autoimmune disorders.
Inventor(s): Francis; John (Longwood, FL), Amirkhosravi; Ali (Longwood, FL), Meyer; Todd (Longwood, FL), Robles-Carrillo; Liza (Rockledge, FL)
Assignee: Adventis Health System/Sunbelt, Inc. (Altamonte Springs, FL)
Application Number:14/555,556
Patent Claims:see list of patent claims

Details for Patent 9,382,321

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up Adventis Health System/Sunbelt, Inc. (Altamonte Springs, FL) 2036-07-30 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Sign Up Adventis Health System/Sunbelt, Inc. (Altamonte Springs, FL) 2036-07-30 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Sign Up Adventis Health System/Sunbelt, Inc. (Altamonte Springs, FL) 2036-07-30 RX Orphan search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20 ➤ Sign Up Adventis Health System/Sunbelt, Inc. (Altamonte Springs, FL) 2036-07-30 RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31 ➤ Sign Up Adventis Health System/Sunbelt, Inc. (Altamonte Springs, FL) 2036-07-30 RX search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31 ➤ Sign Up Adventis Health System/Sunbelt, Inc. (Altamonte Springs, FL) 2036-07-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Covington
Boehringer Ingelheim
Colorcon
Baxter
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.